D-Day For IDEAYA – IDE397 Data To Be Unveiled Tomorrow
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – IDEAYA Biosciences Inc. (IDYA) is scheduled to release a clinical data update from the dose expansion cohort of its phase II trial of IDE397 as monotherapy in MTAP-deletion urothelial and non-small cell lung cancer patients tomorrow, i.e., July 8, 2024, before market
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1455323545-9132d19b253042298a5e50cebc341788.jpg "Credit Scams to Watch Out For")
:max_bytes(150000):strip_icc():format(jpeg)/InsuranceScorehowitworks-5a42f332494ec90036720943.jpg "What Credit Score Should You Have?")
:max_bytes(150000):strip_icc():format(jpeg)/documents3-2c9f0be43694417aa7a597ee195072f1.jpg "How Long Does an Item Appear on My Credit Report?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1190222745-b65de6b6c3b948d2a22db5d28c5b1fb8.jpg "Is My Credit Score Good Enough for a Mortgage?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1390654298-5468501d88fb4e7faca533096301f91c-10635296cf604385879a8a0cdb404622.jpg "Best Strategies for Your Roth 401(k)")